Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veronate for prevention of staphylococcal sepsis in premature infants
NCT00113191Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2004
- Primary completion
- Jun 2006
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of Veronate in staphylococcal infection, sepsis, sponsored by Bristol Myers Squibb. Started May 2004; status: completed.
02
Drugs
Veronate
03
Conditions
staphylococcal infectionsepsis
Beyond the preview
Go deeper on NCT00113191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00113191.